Zhen Su

Insider Reports History

Entity
Individual
Location
85 Wells Avenue, Suite 210, Newton, MA
Signature
/s/ Nancy Smith, Attorney-in-Fact for Zhen Su
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Zhen Su:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. Director Nonstatutory Stock Option (right to buy) 50.6K May 29, 2024 Direct
CytomX Therapeutics, Inc. Director Stock Option (Right to Buy) 38K May 15, 2024 Direct

Insider Reports Filed by Zhen Su

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KPTI Karyopharm Therapeutics Inc. May 29, 2024 1 $0 4 May 30, 2024 Director
CTMX CytomX Therapeutics, Inc. May 15, 2024 1 $0 4 May 17, 2024 Director
CTMX CytomX Therapeutics, Inc. Mar 20, 2024 1 $0 4 Mar 22, 2024 Director
CTMX CytomX Therapeutics, Inc. Mar 20, 2024 0 $0 3 Mar 22, 2024 Director
KPTI Karyopharm Therapeutics Inc. Aug 31, 2023 1 $0 4 Sep 1, 2023 Director
KPTI Karyopharm Therapeutics Inc. Aug 31, 2023 0 $0 3 Sep 1, 2023 Director